They have shown that there was no consistent association of these polymorphisms or respective haplotypes with MS and that there was no association of CT60 genotypes with T cell expression of ICOS and CTLA-4 after in vitro stimulation [135]. This evidence concerns the gene ICOS and myeloid sarcoma.